A new method of treating Parkinson's disease is Ruimi DBS robotic surgery

图片13.png

Parkinson's disease (PD) is a common degenerative disease of the nervous system. It is more common in the elderly. The average age of onset of the disease is about 60 years. It is less common in young people under the age of 40.The prevalence of PD in people over 65 years of age in our country is about 1.7%.

 

The onset of Parkinson's disease is hidden, and its progression is slow.The first symptom is usually a tremor or a clumsy movement of one limb, which in turn affects the opposite limb.Clinically, this is mainly manifested in the form of static tremor, slow movements, myotonia and impaired posture when walking.In recent years, more and more people have noticed that non-motor symptoms such as depression, constipation and sleep disorders are also common complaints of patients with Parkinson's disease, and their impact on patients' quality of life even exceeds motor symptoms.

 

DBS "God" technology gives new hope to patients with Parkinson's disease

图片14.png

Modern scientific research has not revealed a clear cause of Parkinson's disease, so all modern treatments are aimed at suppressing symptoms.Medications are usually used for control at an early stage, and surgical intervention can be applied in the middle and late stages.When Parkinson's disease progresses, for about four to five years, accompanied by a significant decrease in the effectiveness of drugs and their side effects, such as "switching phenomenon", "abnormal symptoms", etc., it is an appropriate time for surgical interventions such as deep electrical stimulation of the brain, nerve stimulation. regulatory surgery and other methods.With these surgical treatments, it is possible to significantly alleviate the symptoms of Parkinson's disease and improve the quality of life of patients.

 

Deep brain stimulation (DBS), as one of the ways to treat Parkinson's disease, is an important new technology in the field of surgical treatment.It stimulates the nucleus of the brain by emitting electrical impulses through tiny electrodes implanted in the brain, thereby achieving the goal of controlling the patient's symptoms. This is one of the most advanced neural regulation technologies in the world.This technology has been used in the clinic for more than 30 years and has benefited more than 150,000 patients with Parkinson's disease.

 

DBS surgery using the Ruimi robot replaces traditional framework surgery and will more accurately contribute to the development of DBS surgery, further improve the concept of precision and minimally invasive neurosurgery, and significantly improve the effectiveness of surgical interventions.At the same time, it can also be upgraded using the robot's internal software module to expand functionality, which makes DBS surgery even more effective, and the patient's intraoperative pain can be reduced to a greater extent, thereby significantly alleviating symptoms in patients with Parkinson's disease, which contributes to improving the quality of life of patients.

图片15.png

Professor Tian Zengmin

 

The Chief physician, the chief Specialist in Neurological Diseases of Nuolai Medicine, enjoys special State subsidies from the State Council.He studied at the University of Washington Medical School in the USA, as a visiting Professor, for a long time served as Vice President of the Main Naval Hospital and Director of the Army Neurosurgery Center.He is the author of three innovative monographs, especially on the systematic theory and clinical practice of robotic surgery, which have reached an advanced International level.Professor Tian Zengming and his team used Ruimi neurosurgical robots to develop minimally invasive, accurate, effective and safe frameless stereotactic surgery that can treat about 100 functional neurodegenerative diseases such as cerebral palsy, epilepsy, brain hemorrhages, Parkinson's disease, Alzheimer's disease, cerebellar atrophy and the effects of stroke, cerebral infarction.